ReviewIMA fungus2026
The legally protected fungi and lichens in the EU.
Review in IMA fungus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Despite decades of recommendations from the scientific community, fungi have yet to be included in any international legal instruments that regulate wildlife species conservation in the European Union (EU), such as the Bern Convention. However, several EU member states include lists of protected non-lichenized and lichenized fungal species in their national legislation. Most of these legal documents are available only in local languages and are dispersed across national legal databases. To increase the visibility of fungi protected across the EU and facilitate comparisons of these regulations, the first consolidated list of 884 non-lichenized and 787 lichenized fungal taxa protected under the national laws of 18 EU member states is presented. The shortcomings of the current framework for protecting fungal species are highlighted, the distinction between non-binding Red Lists and legally binding species protection is clarified, and improvements to enhance the effectiveness of fungal conservation laws in the EU and beyond are proposed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.